Bristol Myers Squibb Provides Update on Phase 3 CheckMate -73L Trial
Go back to Bristol Myers Squibb Provides Update on Phase 3 CheckMate -73L Trial| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 60.81 -0.02 (0.03%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $60.83 | 52 Week High | $77.12 | |||
| Open | $60.66 | 52 Week Low | $49.03 | |||
| Day High | $61.18 | P/E | 39.49 | |||
| Day Low | $60.24 | EPS | $1.54 | |||
| Volume | 3,010,415 | |||||
